| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 11, 2024 | Oct 15, 2024 | Aprea Therapeutics, Inc. | Director | Buy | 91.3 | +10,000 | 28.79% | ✗ | $26.8K |
| Mar 13, 2024 | Mar 14, 2024 | Aprea Therapeutics, Inc. | Director | Buy | 95.0 | +6,860 | 25.57% | ✗ | $50K |
| Sep 22, 2023 | Sep 25, 2023 | Aptose Biosciences Inc. | Director | Buy | 95.0 | +17,000 | 100.00% | ✗ | $53.4K |
| Jun 6, 2023 | Jun 8, 2023 | Aprea Therapeutics, Inc. | Director | Buy | 91.3 | +10,097 | 62.22% | ✗ | $37K |
| May 18, 2022 | May 19, 2022 | Aprea Therapeutics, Inc. | Director | Buy | 91.3 | +50,000 | 18.62% | ✗ | $35.5K |